Alkeus Pharmaceuticals is a late-stage company developing treatments for serious causes of blindness. Alkeus' Lead Product, ALK-001, is a chemically-modified vitamin A that slows formation of toxic vitamin A dimers.
Location: United States, Massachusetts, Cambridge
Employees: 11-50
Total raised: $150M
Investors 2
| Date | Name | Website |
| 16.06.2023 | Sofinnova ... | sofinnova.... |
| 13.06.2023 | TCG Crosso... | tcgcrossov... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 07.06.2023 | Series B | $150M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 24.04.2024 | Prevent Blindness Declares May as First-ever Inherited Retin... | Prevent Blindness declares the month of May as "Inherited Retinal Disease Genetic Testing Aware... | prweb.com/... |
| 10.01.2024 | Alkeus Presents Positive Interim Data Showing Gildeuretinol ... | - | sofinnova.... |
| 03.11.2023 | Alkeus Presents Positive Gildeuretinol Trial Results Demonst... | - | sofinnova.... |
| 07.06.2023 | Alkeus Pharmaceuticals Raises $150M in Series B Financing | Alkeus Pharmaceuticals, a Cambridge, MA-based biopharmaceutical company that specializes in eye dise... | finsmes.co... |
| 05.06.2023 | Alkeus Announces $150 Million Series B Financing, Supporting... | - | globenewsw... |
| 05.06.2023 | Alkeus Announces $150 Million Series B Financing, Supporting... | - | sofinnova.... |
| 05.06.2023 | Alkeus Announces $150 Million Series B Financing | - | tcgcrossov... |
| 01.02.2016 | Start-ups selected for MassChallenge Startup Summit in Genev... | startuptic... | |
| - | Alkeus Pharmaceuticals | “Alkeus Pharmaceuticals Inc | Transformation in Sight” | fastfounde... |